After years working in labs studying the cell cycle and the genetics of human disease, Gennaro D’Urso founded Genetic Networks, a for-profit company focused on drug discovery. As a teenager, D’Urso lost vision in both of his eyes due to a mysterious eye condition. He later received his first corneal transplant, which allowed him to regain 20/20 vision in one of his eyes. This event led him to switch majors from business to science, and he eventually got his Ph.D. in Molecular Genetics.
Related posts
-
Argo Blockchain shares plunge 19% on weaker Q3 revenue compared to 2023 levels
Argo Blockchain reported a 28% decline in Q3 revenue year-over-year, reflecting continued challenges in the crypto... -
Nexbridge Brings US Treasuries to Bitcoin Blockchain With USTBL Offering
Nexbridge, a digital asset issuer, has introduced USTBL—a regulated gateway for investors to tap into U.S.... -
Mercado Bitcoin Launches MBRL Stablecoin on the TRON Blockchain, Pegged to the Brazilian Real
PRESS RELEASE. São Paulo, November 18, 2024 – Mercado...